These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2975091)

  • 21. [Direct myocardial anti-ischemic effect of diltiazem in the human].
    Kober G; Kästner R; Hopf R; Kaltenbach M
    Z Kardiol; 1986 Jul; 75(7):386-93. PubMed ID: 2945332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial protection by intracoronary nicardipine administration during percutaneous transluminal coronary angioplasty.
    Hanet C; Rousseau MF; Vincent MF; Lavenne-Pardonge E; Pouleur H
    Am J Cardiol; 1987 May; 59(12):1035-40. PubMed ID: 2953226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of gallopamil on myocardial ischaemia during percutaneous transluminal coronary angioplasty.
    Rauch B; Neumann J; Richardt G; Kranzhöfer R; Barth R; Zimmermann R; Koch HP; Tillmanns H; Schömig A
    Drugs; 1991; 42 Suppl 1():31-6. PubMed ID: 1718692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial lactate release after intracoronary verapamil application in humans: acute effects of intracoronary verapamil on systemic and coronary hemodynamics, myocardial metabolism, and norepinephrine levels.
    Oldenburg O; Eggebrecht H; Gutersohn A; Schaar J; Brauck K; Haude M; Erbel R; Baumgart D
    Cardiovasc Drugs Ther; 2001 Jan; 15(1):55-61. PubMed ID: 11504164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous dipyridamole-induced myocardial ischemia during percutaneous transluminal coronary angioplasty in humans.
    Klein AL; Marquis JF; Higginson LA; Morton BC; Williams WL; Davies RA; Beanlands DS
    Am J Cardiol; 1989 Feb; 63(7):419-22. PubMed ID: 2521767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional cardioprotection by subselective intracoronary nifedipine is not due to enhanced collateral flow during coronary angioplasty.
    Pop G; Serruys PW; Piscione F; de Feyter PJ; van den Brand M; Huizer T; de Jong JW; Hugenholtz PG
    Int J Cardiol; 1987 Jul; 16(1):27-41. PubMed ID: 2956200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Improved occlusion tolerance time by continuous coronary perfusion with a modified Grüntzig coronary angioplasty catheter].
    Busch U; Erbel R; Clas W; Pfeiffer U; Meyer J; Blümel G; Blömer H
    Z Kardiol; 1985 Aug; 74(8):435-9. PubMed ID: 2931911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial coronary occlusion improves tolerance to subsequent prolonged balloon inflations.
    Heibig J; Bolli R; Harris S
    Cathet Cardiovasc Diagn; 1989 Feb; 16(2):99-102. PubMed ID: 2521578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myocardial protection during transient coronary artery occlusion in man: beneficial effects of regional beta-adrenergic blockade.
    Zalewski A; Goldberg S; Dervan JP; Slysh S; Maroko PR
    Circulation; 1986 Apr; 73(4):734-9. PubMed ID: 2868812
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antianginal and myocardial metabolic properties of verapamil in coronary artery disease.
    Ferlinz J; Turbow ME
    Am J Cardiol; 1980 Dec; 46(6):1019-26. PubMed ID: 7446416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardioprotective effect of intracoronary nifedipine during percutaneous transluminal coronary angioplasty. A French double-blind cross-over multicentre study.
    Juillière Y; Danchin N; Bertrand ME; Bassand JP; Bory M; Bigonzi F; Grolleau R; Lablanche JM; Barragan P; Gaspard P
    Int J Cardiol; 1993 Apr; 39(1):43-8. PubMed ID: 8407006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anti-ischemic effect of verapamil within the scope of interventional recanalization].
    Oldenburg O; Baumgart D; Schaar J; Eggebrecht H; Caspari G; Haude M; Erbel R
    Herz; 1999 Nov; 24(7):581-6. PubMed ID: 10609165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pretreatment with intracoronary enalaprilat protects human myocardium during percutaneous coronary angioplasty.
    Leesar MA; Jneid H; Tang XL; Bolli R
    J Am Coll Cardiol; 2007 Apr; 49(15):1607-1610. PubMed ID: 17433950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary sinus pH during percutaneous transluminal coronary angioplasty: early development of acidosis during myocardial ischaemia in man.
    Crake T; Crean PA; Shapiro LM; Rickards AF; Poole-Wilson PA
    Br Heart J; 1987 Aug; 58(2):110-5. PubMed ID: 2956980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of transient myocardial ischemia by computer analysis of standard and signal-averaged high-frequency electrocardiograms in patients undergoing percutaneous transluminal coronary angioplasty.
    Abboud S; Cohen RJ; Selwyn A; Ganz P; Sadeh D; Friedman PL
    Circulation; 1987 Sep; 76(3):585-96. PubMed ID: 2957111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial protection during percutaneous transluminal coronary angioplasty: effects of trimetazidine.
    Kober G; Buck T; Sievert H; Vallbracht C
    Eur Heart J; 1992 Aug; 13(8):1109-15. PubMed ID: 1505561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial protection by intravenous diltiazem during angioplasty of single-vessel coronary artery disease.
    Bonnier JJ; Huizer T; Troquay R; van Es GA; de Jong JW
    Am J Cardiol; 1990 Jul; 66(2):145-50. PubMed ID: 2196772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coronary venous lipid peroxide concentrations after coronary angioplasty: correlation with biochemical and electrocardiographic evidence of myocardial ischaemia.
    Oldroyd KG; Paterson JR; Rumley AG; Eteiba H; Rae AP; Shepherd J; Cobbe SM; Hutton I
    Br Heart J; 1992 Jul; 68(1):43-7. PubMed ID: 1515290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of nicardipine on determinants of myocardial ischemia occurring during acute coronary occlusion produced by percutaneous transluminal coronary angioplasty.
    Feldman RL; MacDonald RG; Hill JA; Pepine CJ
    Am J Cardiol; 1987 Aug; 60(4):267-70. PubMed ID: 2441586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of intracoronary nitroglycerin administration on poststenotic vascular diameter before and following transluminal coronary angioplasty].
    Bernauer R; Schulz W; Kober G
    Z Kardiol; 1986 Jan; 75(1):19-26. PubMed ID: 2938350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.